Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Induced Pluripotent Stem Cells (iPSCs) Revenue 1.4 Market Analysis by Type 1.4.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Human iPSCs 1.4.3 Mouse iPSCs 1.5 Market by Application 1.5.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Application: 2020 VS 2026 1.5.2 Academic Research 1.5.3 Drug Development and Discovery 1.5.4 Toxicity Screening 1.5.5 Regenerative Medicine 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Induced Pluripotent Stem Cells (iPSCs) Market Perspective (2015-2026) 2.2 Induced Pluripotent Stem Cells (iPSCs) Growth Trends by Regions 2.2.1 Induced Pluripotent Stem Cells (iPSCs) Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Induced Pluripotent Stem Cells (iPSCs) Historic Market Share by Regions (2015-2020) 2.2.3 Induced Pluripotent Stem Cells (iPSCs) Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Induced Pluripotent Stem Cells (iPSCs) Market Growth Strategy 2.3.6 Primary Interviews with Key Induced Pluripotent Stem Cells (iPSCs) Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Induced Pluripotent Stem Cells (iPSCs) Players by Market Size 3.1.1 Global Top Induced Pluripotent Stem Cells (iPSCs) Players by Revenue (2015-2020) 3.1.2 Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Players (2015-2020) 3.1.3 Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Concentration Ratio 3.2.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Induced Pluripotent Stem Cells (iPSCs) Revenue in 2019 3.3 Induced Pluripotent Stem Cells (iPSCs) Key Players Head office and Area Served 3.4 Key Players Induced Pluripotent Stem Cells (iPSCs) Product Solution and Service 3.5 Date of Enter into Induced Pluripotent Stem Cells (iPSCs) Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Induced Pluripotent Stem Cells (iPSCs) Historic Market Size by Type (2015-2020) 4.2 Global Induced Pluripotent Stem Cells (iPSCs) Forecasted Market Size by Type (2021-2026) 5 Induced Pluripotent Stem Cells (iPSCs) Breakdown Data by Application (2015-2026) 5.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2015-2020) 5.2 Global Induced Pluripotent Stem Cells (iPSCs) Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Induced Pluripotent Stem Cells (iPSCs) Market Size (2015-2020) 6.2 Induced Pluripotent Stem Cells (iPSCs) Key Players in North America (2019-2020) 6.3 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2015-2020) 6.4 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2015-2020) 7 Europe 7.1 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size (2015-2020) 7.2 Induced Pluripotent Stem Cells (iPSCs) Key Players in Europe (2019-2020) 7.3 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2015-2020) 7.4 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2015-2020) 8 China 8.1 China Induced Pluripotent Stem Cells (iPSCs) Market Size (2015-2020) 8.2 Induced Pluripotent Stem Cells (iPSCs) Key Players in China (2019-2020) 8.3 China Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2015-2020) 8.4 China Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2015-2020) 9 Japan 9.1 Japan Induced Pluripotent Stem Cells (iPSCs) Market Size (2015-2020) 9.2 Induced Pluripotent Stem Cells (iPSCs) Key Players in Japan (2019-2020) 9.3 Japan Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2015-2020) 9.4 Japan Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Market Size (2015-2020) 10.2 Induced Pluripotent Stem Cells (iPSCs) Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2015-2020) 10.4 Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2015-2020) 11 India 11.1 India Induced Pluripotent Stem Cells (iPSCs) Market Size (2015-2020) 11.2 Induced Pluripotent Stem Cells (iPSCs) Key Players in India (2019-2020) 11.3 India Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2015-2020) 11.4 India Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Induced Pluripotent Stem Cells (iPSCs) Market Size (2015-2020) 12.2 Induced Pluripotent Stem Cells (iPSCs) Key Players in Central & South America (2019-2020) 12.3 Central & South America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2015-2020) 12.4 Central & South America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2015-2020) 13Key Players Profiles 13.1 Fujifilm Holding Corporation (CDI) 13.1.1 Fujifilm Holding Corporation (CDI) Company Details 13.1.2 Fujifilm Holding Corporation (CDI) Business Overview and Its Total Revenue 13.1.3 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Introduction 13.1.4 Fujifilm Holding Corporation (CDI) Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2015-2020)) 13.1.5 Fujifilm Holding Corporation (CDI) Recent Development 13.2 Ncardia 13.2.1 Ncardia Company Details 13.2.2 Ncardia Business Overview and Its Total Revenue 13.2.3 Ncardia Induced Pluripotent Stem Cells (iPSCs) Introduction 13.2.4 Ncardia Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2015-2020) 13.2.5 Ncardia Recent Development 13.3 Sumitomo Dainippon Pharma 13.3.1 Sumitomo Dainippon Pharma Company Details 13.3.2 Sumitomo Dainippon Pharma Business Overview and Its Total Revenue 13.3.3 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Introduction 13.3.4 Sumitomo Dainippon Pharma Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2015-2020) 13.3.5 Sumitomo Dainippon Pharma Recent Development 13.4 Astellas Pharma Inc 13.4.1 Astellas Pharma Inc Company Details 13.4.2 Astellas Pharma Inc Business Overview and Its Total Revenue 13.4.3 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Introduction 13.4.4 Astellas Pharma Inc Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2015-2020) 13.4.5 Astellas Pharma Inc Recent Development 13.5 Fate Therapeutics, Inc 13.5.1 Fate Therapeutics, Inc Company Details 13.5.2 Fate Therapeutics, Inc Business Overview and Its Total Revenue 13.5.3 Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Introduction 13.5.4 Fate Therapeutics, Inc Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2015-2020) 13.5.5 Fate Therapeutics, Inc Recent Development 13.6 Pluricell Biotech 13.6.1 Pluricell Biotech Company Details 13.6.2 Pluricell Biotech Business Overview and Its Total Revenue 13.6.3 Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Introduction 13.6.4 Pluricell Biotech Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2015-2020) 13.6.5 Pluricell Biotech Recent Development 13.7 Cell Inspire Biotechnology 13.7.1 Cell Inspire Biotechnology Company Details 13.7.2 Cell Inspire Biotechnology Business Overview and Its Total Revenue 13.7.3 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Introduction 13.7.4 Cell Inspire Biotechnology Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2015-2020) 13.7.5 Cell Inspire Biotechnology Recent Development 13.8 ReproCELL 13.8.1 ReproCELL Company Details 13.8.2 ReproCELL Business Overview and Its Total Revenue 13.8.3 ReproCELL Induced Pluripotent Stem Cells (iPSCs) Introduction 13.8.4 ReproCELL Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2015-2020) 13.8.5 ReproCELL Recent Development 14Analyst's Viewpoints/Conclusions 15Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Induced Pluripotent Stem Cells (iPSCs) Key Market Segments Table 2. Key Players Covered: Ranking by Induced Pluripotent Stem Cells (iPSCs) Revenue Table 3. Ranking of Global Top Induced Pluripotent Stem Cells (iPSCs) Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Human iPSCs Table 6. Key Players of Mouse iPSCs Table 7. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 8. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Regions (US$ Million): 2020 VS 2026 Table 9. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Regions (2015-2020) (US$ Million) Table 10. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Regions (2015-2020) Table 11. Global Induced Pluripotent Stem Cells (iPSCs) Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 12. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Regions (2021-2026) Table 13. Market Top Trends Table 14. Key Drivers: Impact Analysis Table 15. Key Challenges Table 16. Induced Pluripotent Stem Cells (iPSCs) Market Growth Strategy Table 17. Main Points Interviewed from Key Induced Pluripotent Stem Cells (iPSCs) Players Table 18. Global Induced Pluripotent Stem Cells (iPSCs) Revenue by Players (2015-2020) (Million US$) Table 19. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Players (2015-2020) Table 20. Global Top Induced Pluripotent Stem Cells (iPSCs) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Induced Pluripotent Stem Cells (iPSCs) as of 2019) Table 21. Global Induced Pluripotent Stem Cells (iPSCs) by Players Market Concentration Ratio (CR5 and HHI) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Induced Pluripotent Stem Cells (iPSCs) Product Solution and Service Table 24. Date of Enter into Induced Pluripotent Stem Cells (iPSCs) Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2015-2020) (Million US$) Table 27. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Share by Type (2015-2020) Table 28. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Type (2021-2026) Table 29. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Share by Application (2015-2020) Table 30. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2015-2020) (Million US$) Table 31. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Share by Application (2021-2026) Table 32. North America Key Players Induced Pluripotent Stem Cells (iPSCs) Revenue (2019-2020) (Million US$) Table 33. North America Key Players Induced Pluripotent Stem Cells (iPSCs) Market Share (2019-2020) Table 34. North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2015-2020) (Million US$) Table 35. North America Induced Pluripotent Stem Cells (iPSCs) Market Share by Type (2015-2020) Table 36. North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2015-2020) (Million US$) Table 37. North America Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2015-2020) Table 38. Europe Key Players Induced Pluripotent Stem Cells (iPSCs) Revenue (2019-2020) (Million US$) Table 39. Europe Key Players Induced Pluripotent Stem Cells (iPSCs) Market Share (2019-2020) Table 40. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2015-2020) (Million US$) Table 41. Europe Induced Pluripotent Stem Cells (iPSCs) Market Share by Type (2015-2020) Table 42. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2015-2020) (Million US$) Table 43. Europe Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2015-2020) Table 44. China Key Players Induced Pluripotent Stem Cells (iPSCs) Revenue (2019-2020) (Million US$) Table 45. China Key Players Induced Pluripotent Stem Cells (iPSCs) Market Share (2019-2020) Table 46. China Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2015-2020) (Million US$) Table 47. China Induced Pluripotent Stem Cells (iPSCs) Market Share by Type (2015-2020) Table 48. China Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2015-2020) (Million US$) Table 49. China Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2015-2020) Table 50. Japan Key Players Induced Pluripotent Stem Cells (iPSCs) Revenue (2019-2020) (Million US$) Table 51. Japan Key Players Induced Pluripotent Stem Cells (iPSCs) Market Share (2019-2020) Table 52. Japan Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2015-2020) (Million US$) Table 53. Japan Induced Pluripotent Stem Cells (iPSCs) Market Share by Type (2015-2020) Table 54. Japan Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2015-2020) (Million US$) Table 55. Japan Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2015-2020) Table 56. Southeast Asia Key Players Induced Pluripotent Stem Cells (iPSCs) Revenue (2019-2020) (Million US$) Table 57. Southeast Asia Key Players Induced Pluripotent Stem Cells (iPSCs) Market Share (2019-2020) Table 58. Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2015-2020) (Million US$) Table 59. Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Market Share by Type (2015-2020) Table 60. Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2015-2020) (Million US$) Table 61. Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2015-2020) Table 62. India Key Players Induced Pluripotent Stem Cells (iPSCs) Revenue (2019-2020) (Million US$) Table 63. India Key Players Induced Pluripotent Stem Cells (iPSCs) Market Share (2019-2020) Table 64. India Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2015-2020) (Million US$) Table 65. India Induced Pluripotent Stem Cells (iPSCs) Market Share by Type (2015-2020) Table 66. India Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2015-2020) (Million US$) Table 67. India Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2015-2020) Table 68. Central & South America Key Players Induced Pluripotent Stem Cells (iPSCs) Revenue (2019-2020) (Million US$) Table 69. Central & South America Key Players Induced Pluripotent Stem Cells (iPSCs) Market Share (2019-2020) Table 70. Central & South America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2015-2020) (Million US$) Table 71. Central & South America Induced Pluripotent Stem Cells (iPSCs) Market Share by Type (2015-2020) Table 72. Central & South America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2015-2020) (Million US$) Table 73. Central & South America Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2015-2020) Table 74. Fujifilm Holding Corporation (CDI) Company Details Table 75. Fujifilm Holding Corporation (CDI) Business Overview Table 76. Fujifilm Holding Corporation (CDI) Product Table 77. Fujifilm Holding Corporation (CDI) Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2015-2020) (Million US$) Table 78. Fujifilm Holding Corporation (CDI) Recent Development Table 79. Ncardia Company Details Table 80. Ncardia Business Overview Table 81. Ncardia Product Table 82. Ncardia Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2015-2020) (Million US$) Table 83. Ncardia Recent Development Table 84. Sumitomo Dainippon Pharma Company Details Table 85. Sumitomo Dainippon Pharma Business Overview Table 86. Sumitomo Dainippon Pharma Product Table 87. Sumitomo Dainippon Pharma Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2015-2020) (Million US$) Table 88. Sumitomo Dainippon Pharma Recent Development Table 89. Astellas Pharma Inc Company Details Table 90. Astellas Pharma Inc Business Overview Table 91. Astellas Pharma Inc Product Table 92. Astellas Pharma Inc Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2015-2020) (Million US$) Table 93. Astellas Pharma Inc Recent Development Table 94. Fate Therapeutics, Inc Company Details Table 95. Fate Therapeutics, Inc Business Overview Table 96. Fate Therapeutics, Inc Product Table 97. Fate Therapeutics, Inc Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2015-2020) (Million US$) Table 98. Fate Therapeutics, Inc Recent Development Table 99. Pluricell Biotech Company Details Table 100. Pluricell Biotech Business Overview Table 101. Pluricell Biotech Product Table 102. Pluricell Biotech Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2015-2020) (Million US$) Table 103. Pluricell Biotech Recent Development Table 104. Cell Inspire Biotechnology Company Details Table 105. Cell Inspire Biotechnology Business Overview Table 106. Cell Inspire Biotechnology Product Table 107. Cell Inspire Biotechnology Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2015-2020) (Million US$) Table 108. Cell Inspire Biotechnology Recent Development Table 109. ReproCELL Business Overview Table 110. ReproCELL Product Table 111. ReproCELL Company Details Table 112. ReproCELL Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2015-2020) (Million US$) Table 113. ReproCELL Recent Development Table 114. Research Programs/Design for This Report Table 115. Key Data Information from Secondary Sources Table 116. Key Data Information from Primary Sources List of Figures Figure 1. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Type: 2020 VS 2026 Figure 2. Human iPSCs Features Figure 3. Mouse iPSCs Features Figure 4. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Application: 2020 VS 2026 Figure 5. Academic Research Case Studies Figure 6. Drug Development and Discovery Case Studies Figure 7. Toxicity Screening Case Studies Figure 8. Regenerative Medicine Case Studies Figure 9. Induced Pluripotent Stem Cells (iPSCs) Report Years Considered Figure 10. Global Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth 2015-2026 (US$ Million) Figure 11. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Regions: 2020 VS 2026 Figure 12. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Regions (2021-2026) Figure 13. Porter's Five Forces Analysis Figure 14. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Players in 2019 Figure 15. Global Top Induced Pluripotent Stem Cells (iPSCs) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Induced Pluripotent Stem Cells (iPSCs) as of 2019 Figure 16. The Top 10 and 5 Players Market Share by Induced Pluripotent Stem Cells (iPSCs) Revenue in 2019 Figure 17. North America Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2015-2020) (Million US$) Figure 18. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2015-2020) (Million US$) Figure 19. China Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Japan Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2015-2020) (Million US$) Figure 21. Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2015-2020) (Million US$) Figure 22. India Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Central & South America Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2015-2020) (Million US$) Figure 24. Fujifilm Holding Corporation (CDI) Total Revenue (US$ Million): 2019 Compared with 2018 Figure 25. Fujifilm Holding Corporation (CDI) Revenue Growth Rate in Induced Pluripotent Stem Cells (iPSCs) Business (2015-2020) Figure 26. Ncardia Total Revenue (US$ Million): 2019 Compared with 2018 Figure 27. Ncardia Revenue Growth Rate in Induced Pluripotent Stem Cells (iPSCs) Business (2015-2020) Figure 28. Sumitomo Dainippon Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 29. Sumitomo Dainippon Pharma Revenue Growth Rate in Induced Pluripotent Stem Cells (iPSCs) Business (2015-2020) Figure 30. Astellas Pharma Inc Total Revenue (US$ Million): 2019 Compared with 2018 Figure 31. Astellas Pharma Inc Revenue Growth Rate in Induced Pluripotent Stem Cells (iPSCs) Business (2015-2020) Figure 32. Fate Therapeutics, Inc Total Revenue (US$ Million): 2019 Compared with 2018 Figure 33. Fate Therapeutics, Inc Revenue Growth Rate in Induced Pluripotent Stem Cells (iPSCs) Business (2015-2020) Figure 34. Pluricell Biotech Total Revenue (US$ Million): 2019 Compared with 2018 Figure 35. Pluricell Biotech Revenue Growth Rate in Induced Pluripotent Stem Cells (iPSCs) Business (2015-2020) Figure 36. Cell Inspire Biotechnology Total Revenue (US$ Million): 2019 Compared with 2018 Figure 37. Cell Inspire Biotechnology Revenue Growth Rate in Induced Pluripotent Stem Cells (iPSCs) Business (2015-2020) Figure 38. ReproCELL Total Revenue (US$ Million): 2019 Compared with 2018 Figure 39. ReproCELL Revenue Growth Rate in Induced Pluripotent Stem Cells (iPSCs) Business (2015-2020) Figure 40. Bottom-up and Top-down Approaches for This Report Figure 41. Data Triangulation Figure 42. Key Executives Interviewed

Fujifilm Holding Corporation (CDI) Ncardia Sumitomo Dainippon Pharma Astellas Pharma Inc Fate Therapeutics, Inc Pluricell Biotech Cell Inspire Biotechnology ReproCELL